Vol. 3, No. 6 — June 2026Independent since 2024

TheCompound Journal

Reporting on incretins, compounding & the peptide supply chain

A monthly journal of record.
30 issues · 32 contributors
Not medical advice. We sell nothing.

Container closure

The cake tells you something, and it is not purity

Dye ingress and microbial immersion are probabilistic. Vacuum decay, high-voltage leak detection and helium mass spectrometry are deterministic and far more sensitive.

Sterility is a property of a system, not of a solution, and the system includes the glass, the elastomeric closure, the aluminium overseal and the interference fit between them. A batch filled under impeccable conditions into vials whose stoppers do not seat correctly is not a sterile batch after the first week of transport. This is well understood in regulated manufacture, where container closure integrity is a validated attribute tested at defined intervals across shelf life, and almost entirely absent from the documentation available in the research-peptide trade.

Two questions that share a piece of paper

Consider what happens physically when a certificate is produced. A few milligrams of lyophilised powder are weighed, dissolved in an aqueous mobile phase with an organic modifier, injected onto a reversed-phase column and separated over a programmed gradient while an ultraviolet detector records absorbance. The output is a trace. Software integrates the areas beneath its features, and the main peak area as a proportion of the total becomes the purity figure.

Every step of that procedure is blind to microbial contamination. A bacterial cell contributes no ultraviolet-absorbing peak at any retention time a peptide method would record. Endotoxin, a lipopolysaccharide, is not usefully detected at the wavelengths used for peptide bond absorbance and would in any case be present at a mass fraction several orders of magnitude below any integration threshold in commercial use. A vial holding a hundred colony-forming units and a vial holding none produce chromatograms that no analyst could distinguish.

This is not a defect of the method. Reversed-phase chromatography is an excellent way of determining what proportion of the chromatographically visible material is the intended species, and that is what it is being asked. The defect is in the reading. A document answering one question is being filed as evidence about five.

Three method families, and what each returns

The gel-clot method is the oldest and simplest: lysate is combined with the sample, incubated, and the tube inverted. A firm clot that does not slip is a positive. It is a limit test, and by testing serial dilutions it becomes semi-quantitative. Its virtues are robustness and independence from instrumentation; its limitation is resolution.

Turbidimetric methods read the increasing turbidity produced by clotting protein formation, either as an endpoint at fixed time or kinetically as the time to reach a defined turbidity. Chromogenic methods substitute a synthetic peptide substrate that releases a chromophore when cleaved by the activated enzyme, and read absorbance. The kinetic chromogenic variant — measuring the time to a defined absorbance change against a standard curve — is the method of record for most modern release testing, offering quantitation across several orders of magnitude from a small sample volume.

All three are compendial, all three require a demonstration that the sample matrix neither inhibits nor enhances the reaction, and all three are calibrated against an international reference endotoxin rather than against a mass. A result reported without the method and without the inhibition-enhancement result is, once again, a number without a procedure.1

Between sterile and unexamined lies a measurable middle. A total viable count on a powder is neither expensive nor slow, it would tell a buyer more about a supplier’s environment than any other single determination, and it is not on any price list in this market.

Twenty containers, fourteen days, destroyed. That is the entire empirical basis of the finished-product sterility claim.

On the compendial sterility test

Container closure integrity, method by method

The compendial guidance divides leak test methods into probabilistic and deterministic families and is explicit about preferring the second. Probabilistic methods — dye ingress under vacuum, microbial immersion challenge, bubble emission — rely on a sequence of stochastic events, and their sensitivity is poor and hard to quantify. A dye ingress test can pass a container with a defect large enough to admit an organism, because the dye happened not to travel.

Deterministic methods measure a physical quantity with a continuous response. Vacuum decay monitors pressure rise in an evacuated test chamber. High-voltage leak detection measures current through the container wall and is well suited to liquid-filled units. Laser-based headspace analysis interrogates the gas inside a sealed container non-destructively, which permits repeated measurement of the same unit across a stability programme. Helium mass spectrometry resolves the smallest defects of any method in routine use.

The threshold that matters is the maximum allowable leakage limit — the defect size below which microbial ingress does not occur under the conditions the product will see. Establishing it for a given package is a piece of work, and once established it converts an argument about seals into a measurement.2

What twenty companies answered on five sterility questions
QuestionAnsweredDeclinedNo reply
Fill route: aseptic or terminal947
Pre-filtration bioburden determined749
Filter integrity tested post-use5411
Aseptic process simulation performed3512
Endotoxin determined on finished product4412
Questions were sent twice, four weeks apart, to the published contact address of each company. Declined denotes a reply that engaged with the question and refused it; no reply denotes two unanswered messages. Four of the declines cited the research-use-only basis of sale, which the Journal regards as a legally sound answer.

Fourth puncture, fifth puncture: the elastomer as a physical object

A multiple-dose closure is engineered to reseal after a defined number of penetrations by a needle of defined gauge, and the qualification data behind that claim is generated with a specific needle geometry at a specific rate. Beyond that number, the resealing behaviour is not characterised, and the failure is not usually dramatic: the elastomer simply stops closing fully behind the needle track.

Two related phenomena deserve naming. Coring is the removal of a fragment of elastomer by the needle tip, which both leaves a particle in the solution and creates a channel that does not reseal. It is more likely with larger-gauge needles, with repeated penetration through the same point, and with a needle that has already been used and blunted. Fragmentation testing is a compendial requirement for elastomeric closures precisely because of it.

The practical inference available to a reader is not a recommendation, because this publication does not make those. It is an observation about the object: a closure has a puncture budget, that budget is a number somebody determined experimentally, nobody in this trade publishes it, and the elastomer behaves according to the number rather than according to what anybody assumed. Rotating the entry point and using a fresh needle each time are answers to a mechanical problem, not to a microbiological one.

Particulate matter, visible and subvisible

Injectable products are required to be essentially free of visible particulates, and every container in a regulated batch is inspected against dark and light backgrounds under defined illumination. The detection threshold for a trained inspector is somewhere near fifty microns for a contrasting particle, and the inspection is a hundred per cent operation rather than a sample-based one, which makes it unusual among quality tests.

Subvisible particles are counted instrumentally. Light obscuration is the primary compendial method, with microscopic membrane counting as the alternative when the sample defeats it. For a small-volume injection the limits are six thousand particles at or above ten microns and six hundred at or above twenty-five microns per container. Products that are themselves proteinaceous get a distinct chapter, because inherent aggregates complicate the counting and the method has to distinguish them from extrinsic contamination.

For a private buyer, visible inspection is the one quality operation available without instrumentation, and it is worth doing carefully: a lyophilised cake that has collapsed to a glassy disc, a reconstituted solution showing a faint tyndall haze on rotation, a fibre against a dark card. None of those is a sterility finding. All of them are evidence about how the product was made and how it has travelled.34

What the cake tells you

A lyophilised plug is a physical record of the cycle that produced it. A well-formed cake occupies close to the volume of the solution that was frozen, has a matte, uniform appearance, retains a defined edge where it met the glass, and dissolves rapidly and completely on addition of diluent. That appearance indicates that the product was frozen below its critical formulation temperature and dried without the structure collapsing.

Departures are informative. A shrunken, translucent or glassy plug suggests collapse during primary drying — the ice sublimed faster than the amorphous matrix could hold its structure — which is associated with higher residual moisture and a shorter shelf life. A cake that has partly detached and moves freely suggests mechanical handling after drying, which is cosmetic. A cake showing melt-back at the base, or a visible meniscus line, suggests a shelf temperature excursion. Slow or incomplete reconstitution suggests either collapse or an unfavourable surface.

None of these observations is a purity finding, a sterility finding or an endotoxin finding, and it is important not to overclaim. What they are is the only direct evidence about process control that arrives in the box, and reading them costs nothing. The Journal photographs every cake it receives before opening the vial, for exactly that reason.5

Sterility is a property of a process rather than a result of a test. Twenty units drawn from a batch of ten thousand have limited power to detect low-level contamination; the confidence comes from validation, environmental monitoring and media fills, none of which appears on a document.

A note on method and sourcing

The compendial material in this article is drawn from the current general chapters of the United States Pharmacopeia and the European Pharmacopoeia, read in the original rather than in summary, and from the international standards on aseptic processing and on laboratory competence. Where a chapter has changed status recently — as the recombinant reagent chapters have — we say so, because a reader consulting an older edition will find a different framing.

Where the Journal reports a number it obtained itself, it states the laboratory’s accreditation status, the method family, whether method suitability was established, and the number of determinations. Where we report what a company told us, we distinguish an answer from a refusal and a refusal from a non-response, because those three things are routinely collapsed in coverage of this trade and they are not the same.

Corrections to this department are handled by the standards desk, which reads every letter and records the outcome in the log. Readers who believe a paragraph here overstates its evidence are asked to write to standards@compoundjournal.com; readers with documents to send, including certificates they would like read, should write to letters@compoundjournal.com. We do not publish correspondents’ names without permission and we do not identify the source of a certificate.

The sterility half is not solvable within the current economics, and it would be dishonest to pretend otherwise. Fourteen days, two media, a destroyed container and a statistical yield that passes most contaminated batches: no commercial testing service can build a product out of that for private buyers, and none has tried. The honest position is that this attribute is not verifiable downstream and must be assured upstream or not at all.

References

  1. United States Pharmacopeia. General Chapter ⟨85⟩ Bacterial Endotoxins Test. USP–NF, Rockville, MD.
  2. United States Pharmacopeia. General Chapter ⟨1207⟩ Package Integrity Evaluation — Sterile Products. USP–NF, Rockville, MD.
  3. United States Pharmacopeia. General Chapter ⟨788⟩ Particulate Matter in Injections. USP–NF, Rockville, MD.
  4. United States Pharmacopeia. General Chapter ⟨787⟩ Subvisible Particulate Matter in Therapeutic Protein Injections. USP–NF, Rockville, MD.
  5. “Cake appearance, collapse temperature and residual moisture in lyophilised peptide formulations.” AAPS PharmSciTech. 2019;20(7):286.

Letters to the Editor

4 printed

Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.

Container closure integrity is the quiet half of this subject. A perfectly filled vial with a poorly seated stopper is not a sterile product a month later, and nothing on any document describes the seal. A crimp that turns under finger pressure is a finding a buyer can make without any instrument at all.

T. Salmi, Oulu

The Journal replies

That is a check worth adding to the standing list, and it requires nothing but a hand. We have added it under the arrival inspection.

Vacuum in a lyophilised vial is a useful and under-used indicator. A vial stoppered under partial vacuum draws diluent in when the needle is inserted; one that does not has either lost its seal or was never stoppered under vacuum. Either answer is worth knowing before you use the contents.

N. Zangwill, Manchester

The Journal replies

A good practical test and a cheap one. It is not proof of integrity and it is a strong prompt to ask a question.

Price competition selects against anything that adds cost without being visible to the buyer at the point of decision. Everything discussed in this piece falls into that category, which is why none of it is offered.

A. Basaraba, Winnipeg, MB

Naming an absence without implying a hazard is a difficult editorial line and your department walks it more carefully than most. Saying that something is unmeasured is a statement about measurement, not about risk.

E. Beauchamp, Ottawa, ON

The Journal replies

That is exactly the line and it is worth stating: an unmeasured quantity is unknown in both directions. We report what has not been established, and nothing follows from that about what would be found.

Related coverage